https://funtrafoo.com/daily-feeds/novaliq-presents-data-from-second-phase-3-trial-of-investigational-treatment-cyclasol-0-1-cyclosporine-ophthalmic-solution-at-the-american-society-of-cataract-and-refractive-surgery-annual-mee/37549/
NOVALIQ PRESENTS DATA FROM SECOND PHASE 3 TRIAL OF INVESTIGATIONAL TREATMENT CYCLASOL® (0.1% CYCLOSPORINE OPHTHALMIC SOLUTION) AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING